Clinical Trial Update: The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on the effect of chemoradiotherapy in patients with refractory pituitary adenomas (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Adenoma

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pituitary Adenomas | Phase 2, Phase 3 | Status: UNKNOWN